Schimanski C C, Linnemann U, Arbogast R, Berger M R
Unit of Toxicology and Chemotherapy, German Cancer Research Centre, 69120 Heidelberg, Germany.
Oncol Rep. 2001 Jan-Feb;8(1):185-8. doi: 10.3892/or.8.1.185.
Liver metastasis, as well as local recurrence, are delineating factors of postoperative survival in patients suffering from colorectal cancer. We set up a PCR-RFLP assay to detect K-ras mutated cells in liver tissue as an indicator of possible isolated tumor cells (ITC) or micro-metastasis at the time of surgery. Sixty-four patients with K-ras codons 12 or 13 mutated colorectal cancer were clinically diagnosed for liver metastasis, as well as by PCR-RFLP assay of DNA from liver biopsies. Macro-metastasis was observed in the liver of 7 patients (11%), with no additional evidence of ITC. Likewise, in the liver of 14 patients (22%) only ITC, but no macro-metastasis was detected. In another 7 patients (11%) there was both, ITC and macro-metastasis. No macro-metastasis or ITC were found in 36 patients (56%). Thus, the PCR-RFLP assay added 14 cases (22%) with potential liver-metastasis to the 14 cases (22%) detected by clinical diagnostic means. T and N status were related to the refined detection and extended classification of liver involvement. We conclude that clinical and PCR-RFLP methods supplement each other and can increase the detection of cases with liver involvement, if applied together.
肝转移以及局部复发是影响结直肠癌患者术后生存的因素。我们建立了一种聚合酶链反应-限制性片段长度多态性分析方法(PCR-RFLP),用于检测肝组织中K-ras基因突变细胞,以此作为手术时可能存在的孤立肿瘤细胞(ITC)或微转移的指标。64例K-ras基因第12或13密码子突变的结直肠癌患者经临床诊断为肝转移,并通过对肝活检组织DNA进行PCR-RFLP分析来确诊。7例患者(11%)肝脏出现大转移灶,未发现其他ITC证据。同样,14例患者(22%)肝脏仅检测到ITC,但未发现大转移灶。另外7例患者(11%)同时存在ITC和大转移灶。36例患者(56%)未发现大转移灶或ITC。因此,PCR-RFLP分析在临床诊断发现的14例(22%)潜在肝转移病例基础上,又增加了14例(22%)。T和N分期与肝脏受累情况的精确检测及扩展分类相关。我们得出结论,如果联合应用,临床方法和PCR-RFLP方法可以相互补充,提高肝脏受累病例的检测率。